Antisense delivery using protamine-oligonucleotide particles
- PMID: 10773093
- PMCID: PMC105384
- DOI: 10.1093/nar/28.10.e45
Antisense delivery using protamine-oligonucleotide particles
Abstract
Protamine, a polycationic peptide (mol. wt 4000-4500), was evaluated as a potential penetration enhancer for phosphodiester antisense oligonucleotides (ODNs). Unique complexes in the form of nanoparticles were spontaneously formed, which we call 'proticles'. The stability of the particles and the ODNs bound into the proticles was examined in foetal calf serum and cell culture medium. FITC-labelled ODNs bound to protamine showed an increased cellular uptake into human histiocytic lymphoma U 937 cells compared to free ODNs. Proticles significantly decreased cellular growth in a cell proliferation assay using ODNs against the c- myc proto-oncogene.
Figures
Similar articles
-
Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides.Eur J Pharm Biopharm. 2005 Jul;60(2):287-94. doi: 10.1016/j.ejpb.2005.01.006. Eur J Pharm Biopharm. 2005. PMID: 15939239
-
Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterization.Eur J Pharm Biopharm. 2005 Apr;59(3):419-29. doi: 10.1016/j.ejpb.2004.04.001. Eur J Pharm Biopharm. 2005. PMID: 15760722
-
Comparison of antisense oligonucleotide drug delivery systems.J Control Release. 2004 Dec 10;100(3):411-23. doi: 10.1016/j.jconrel.2004.08.027. J Control Release. 2004. PMID: 15567506
-
Protamine-oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting.Eur J Pharm Sci. 2015 Jul 30;75:54-9. doi: 10.1016/j.ejps.2015.04.009. Epub 2015 Apr 17. Eur J Pharm Sci. 2015. PMID: 25896372 Review.
-
Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS.J Pharm Sci. 1998 Nov;87(11):1308-15. doi: 10.1021/js9800836. J Pharm Sci. 1998. PMID: 9811482 Review.
Cited by
-
Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.Curr Med Chem. 2015;22(31):3631-51. doi: 10.2174/0929867322666150716114625. Curr Med Chem. 2015. PMID: 26180001 Free PMC article. Review.
-
Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques.Int J Nanomedicine. 2011;6:1279-90. doi: 10.2147/IJN.S18739. Epub 2011 Jun 21. Int J Nanomedicine. 2011. PMID: 21753879 Free PMC article.
-
Recent Advances in the Delivery Carriers and Chemical Conjugation Strategies for Nucleic Acid Drugs.Cancers (Basel). 2021 Aug 1;13(15):3881. doi: 10.3390/cancers13153881. Cancers (Basel). 2021. PMID: 34359781 Free PMC article. Review.
-
Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques.Molecules. 2019 Aug 23;24(17):3072. doi: 10.3390/molecules24173072. Molecules. 2019. PMID: 31450823 Free PMC article. Review.
-
A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future.Pharmaceutics. 2023 Feb 10;15(2):600. doi: 10.3390/pharmaceutics15020600. Pharmaceutics. 2023. PMID: 36839922 Free PMC article. Review.
References
-
- Shi Y., Hutchinson,H.G., Hall,D.J. and Zalewski,A. (1993) Circulation, 88, 1190–1195. - PubMed
-
- Edgington S.M. (1993) Biotechnology, 11, 787–792. - PubMed
-
- Kaddurah-Daouk R., Greene,J.M., Baldwin,A.S.,Jr and Kingston,R.E. (1987) Genes Dev., 1, 347–357. - PubMed
-
- Shi Y., Glynn,J.M., Guilbert,L.J., Cotter,T.G., Bissonnette,R.P. and Green,D.R. (1992) Science, 257, 212–214. - PubMed
-
- Bissonnette R.P., Echeverri,F., Mahboubi,A. and Green,D.R. (1992) Nature, 359, 552–554. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous